Skip to main content
Premium Trial:

Request an Annual Quote

NeuMoDx Molecular Receives CE Mark for Quantitative BK Viral Assay

NEW YORK – NeuMoDx Molecular announced on Wednesday that it has received the CE mark for its viral load monitoring assay.

In collaboration with Milan, Italy-based Sentinel Diagnostics, NeuMoDx developed the Quantitative BK virus (BKV) assay, which is intended to help clinical manage infection in the critical organ transplant patient population. The partnership strengthens the NeuMoDx transplant menu, which already includes tests with CE mark for Epstein–Barr virus and cytomegalovirus viral load monitoring for the management of immunocompromised patients, NeuMoDx said.

The Quantitative BKV virus assay is based on Sentinel Diagnostics' STAT-NAT patented technology and is available in a ready-to-use lyophilized format. The assay is stable at room temperature for two years and provides state of the art performance, according to Ann Arbor, Michigan-based NeuMoDx.

"The availability of the NeuMoDx BKV Quant Assay, along with the previously commercialized NeuMoDx CMV and EBV Quant Assays, moves us significantly closer to providing a comprehensive transplant virology monitoring solution," NeuMoDx President and Chief Operating Officer Sundu Brahmasandra said in a statement.

From extraction to detection, the assay integrates the entire molecular diagnostic process with the first results available in about 60 minutes for viral load tests, NeuMoDx said.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.